Search by Drug Name or NDC

    NDC 65862-0521-05 Naproxen 375 mg/1 Details

    Naproxen 375 mg/1

    Naproxen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is NAPROXEN.

    Product Information

    NDC 65862-0521
    Product ID 65862-521_fff8f484-c574-4e56-9ff5-f56968cdca59
    Associated GPIs 66100060000310
    GCN Sequence Number 008361
    GCN Sequence Number Description naproxen TABLET 375 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 35792
    HICL Sequence Number 003727
    HICL Sequence Number Description NAPROXEN
    Brand/Generic Generic
    Proprietary Name Naproxen
    Proprietary Name Suffix n/a
    Non-Proprietary Name Naproxen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 375
    Active Ingredient Units mg/1
    Substance Name NAPROXEN
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200429
    Listing Certified Through 2025-12-31

    Package

    NDC 65862-0521-05 (65862052105)

    NDC Package Code 65862-521-05
    Billing NDC 65862052105
    Package 500 TABLET in 1 BOTTLE (65862-521-05)
    Marketing Start Date 2011-11-08
    NDC Exclude Flag N
    Pricing Information N/A